Latest Baxter International Stories

2012-09-24 23:04:15

On August 24th, 2012 BusinessWeek reported that Elli Lilly´s experimental new drug for the treatment of Alzheimer´s disease delayed the worsening of mental loss, in a sub-analysis of patients in the earliest stage of the disease, while failing to meet the primary goals of two large trials. The only other therapy in final-stage testing is Baxter International Inc.´s Gammagard, an intravenous solution that is made from human plasma. At the end of February 1994, Baxter announced...

2012-07-06 23:03:42

New study “Global Hemophilia Market Report: 2012 Edition” developed by Koncept Analytics has been recently published by Market Publishers Ltd. According to the study, the global market for hemophilia products has shown continuous growth in the past years growing at 8.96% CAGR from 2006 to 2011 and is projected to expand steadily in the upcoming years. London, UK (PRWEB) July 06, 2012 The global market for hemophilia products has shown continuous growth in the past years growing...

2012-05-19 23:12:04

On April 27th, 2012, Baxter, the company manufacturing Gammagard, announced positive Phase III clinical data of Gammagard Liquid 10% [Immune Globulin Intravenous (Human)], used for treating multifocal motor neuropathy (MMN). Gammagard is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body maintain immunity and fight disease. In February 1994, Baxter announced it was removing Gammagard from the global market because of the possibility that it...

2011-06-09 16:27:00

CHICAGO, June 9, 2011 /PRNewswire/ -- Today a Cook County jury awarded $625,000 to the estate of a 63 year old Chicago area man, Steven Johansen, who was administered Baxter blood thinner that contained a contaminated ingredient Baxter sourced from China. This was the first of hundreds of pending lawsuits on Baxter contaminated Chinese heparin to go to trial. The lawsuits are pending in the Circuit Court of Cook County in Chicago, Illinois before Judge Jennifer Duncan-Brice and in the...

2010-12-06 07:00:00

TAI'AN, China, Dec. 6, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. ("Shandong Taibang") and Guiyang Dalin Biologic Technologies Co., Ltd. ("Dalin"), and its equity investment in Xi'an Huitian Blood Products Co.,...

Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.